UnitedHealth Group’s stock has dropped by 34% in 2025 due to increased visits to doctors and surgeons impacting profits. Investors should look for company guidance on projected EPS increase and MCR decrease. The company will release its 2025 results and 2026 financial guidance on Jan. 27, after suspending its profit forecast in May 2025. For investors, key indicators to watch include EPS, MCR, and operating margin. While caution is advised before purchasing UnitedHealth shares, its current valuation post-plunge may present a long-term investment opportunity. Consider consulting the Motley Fool’s analyst team for top stock recommendations.

Read more at Nasdaq: Don’t Buy UnitedHealth Group Stock Before Jan. 27